About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Pharmacoeconomics
›
Top Articles
Pharmacoeconomics
Public Health
,
Pharmacology
4.4
(top 3%)
Impact Factor
4.8
(top 3%)
extended IF
110
(top 3%)
H-Index
1.6K
authors
3.3K
papers
84.6K
citations
6.2K
citing journals
39.7K
citing authors
Most Cited Articles of Pharmacoeconomics
Title
Year
Citations
The validity and reproducibility of a work productivity and activity impairment instrument
1993
1.6K
The Epidemiology of Obesity: A Big Picture
2015
1.2K
Conducting discrete choice experiments to inform healthcare decision making: a user's guide
2008
807
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II
1999
631
The health economics of bladder cancer: a comprehensive review of the published literature
2003
593
Multi-attribute health status classification systems. Health Utilities Index
1995
586
An introduction to Markov modelling for economic evaluation
1998
578
Handling uncertainty in cost-effectiveness models
2000
544
A comparative review of generic quality-of-life instruments
2000
511
The NICE cost-effectiveness threshold: what it is and what that means
2008
496
Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?
2016
477
The burden of schizophrenia on caregivers: a review
2008
460
Epidemiology and burden of illness of rheumatoid arthritis
2004
446
The Economic Costs of Type 2 Diabetes: A Global Systematic Review
2015
436
Discrete choice experiments in health economics: a review of the literature
2014
401
Multi-attribute preference functions. Health Utilities Index
1995
387
The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?
2000
339
Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment
2006
327
A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials
2014
296
Bayesian methods for evidence synthesis in cost-effectiveness analysis
2006
296
Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy
2009
288
Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996)
2001
278
Standardisation of costs: the Dutch Manual for Costing in economic evaluations
2002
258
Healthcare resource and lost labour costs of migraine headache in the US
1992
256
The health-related quality of life and economic burden of constipation
2005
252
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.